Corcept Therapeutics Incorporated · NASDAQ:CORT
Vieira Roberto Wandenkolk sold 8,333 Corcept Therapeutics Incorporated shares (Form 4)
Traded Oct 2, 2026 · Filed Oct 5, 2026
On Oct 2, 2026, Vieira Roberto Wandenkolk (President, Oncology) sold 8,333 Corcept Therapeutics Incorporated shares at an average US$116.10 for US$967K under a trading plan, leaving 3,946 shares. Filed Oct 5, 2026 (Form 4).
- Sold
- 8,333 shares
- Price
- US$116.10 average (US$114.52 to US$116.59)
- Value
- US$967K
- Holding after
- 3,946 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- President, Oncology
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 2, 2026 | Common Stock | Option exercise | 8,333 | US$21.63 | 12,279 | Direct |
| Oct 2, 2026 | Common Stock | Sale | 1,100 | US$114.52 | 11,179 | Direct |
| Oct 2, 2026 | Common Stock | Sale | 2,086 | US$115.73 | 9,093 | Direct |
| Oct 2, 2026 | Common Stock | Sale | 5,147 | US$116.59 | 3,946 | Direct |
Source
Related
- Corcept Therapeutics Incorporated
- Vieira Roberto Wandenkolk
- Corcept Therapeutics Incorporated shareholders
- Form 4 · Vieira Roberto Wandenkolk · Sep 18, 2026
- Form 4 · Vieira Roberto Wandenkolk · Sep 3, 2026
- Form 4 · Wilson James N · Oct 16, 2026
- Form 4 · Maduck Sean · Oct 5, 2026
- Form 4 · Lyon Joseph Douglas · Oct 5, 2026
- Form 4 · Robb Gary Charles · Sep 28, 2026
- Form 4 · Robb Gary Charles · Sep 18, 2026